A 58-year-old female received a single umbilical cord blood (CB) unit transplantation with reduced intensity conditioning for FLT3+, NPM1+ AML in second complete remission. The preparative regimen consisted of cyclophosphamide, fludarabine, total body irradiation (TBI), and anti-thymocyte globulin (ATG). Tacrolimus and mycophenolate mofetil used for graft-versus-host disease prevention. Engraftment was achieved at day +20, as defined by an absolute neutrophil count >2.5 × 10 9 /L for 2 consecutive days. Standard antibacterial, antifungal, and antiviral prophylaxis included levofloxacin, micafungin during the conditioning period followed by voriconazole starting day +1, and high-dose acyclovir, respectively.Inhaled pentamidine starting on day +28 was substituted for trimethoprim/sulfamethoxazole (TMP/SMX) for Pneumocystis jirovecii pneumonia (PJP) prophylaxis to avoid myelosuppression.The hospital course (Figure 1) was complicated by febrile neutropenia on day +10 with findings of ground glass opacities on chest CT with non-revealing workup, which included negative blood and urine cultures, Aspergillus galactomannan (AG) and (1-3)β-d-glucan (BDG) and bronchoscopy with unremarkable bacterial and mycobacterial staining with no growth on bacterial-, fungal-, mycobacterial-,